TriSalus Life Sciences, Inc.
TLSI
$5.22
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.92% | 67.23% | 62.77% | -2,296.02% | 89.39% |
| Total Depreciation and Amortization | -12.89% | 3.19% | -6.93% | 29.49% | 4.00% |
| Total Amortization of Deferred Charges | -37.45% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.99% | -219.80% | -88.23% | 243.19% | -695.64% |
| Change in Net Operating Assets | 50.58% | -1,220.91% | -112.15% | 185.78% | -337.45% |
| Cash from Operations | 19.18% | -23.51% | -22.80% | 59.15% | -134.54% |
| Capital Expenditure | -181.67% | 9.09% | 82.26% | -108.99% | -474.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 171.95% | -93,500.00% |
| Cash from Investing | -181.67% | 9.09% | 90.57% | 37.05% | -3,606.67% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -4.76% | 4.55% | 0.00% | 0.00% | -4.76% |
| Issuance of Common Stock | 62.05% | 14.58% | 3,603.53% | 203.57% | 75.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -29.63% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -100.06% | -- |
| Cash from Financing | -77.60% | 731.51% | 7,169.77% | -99.89% | 528.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.51% | 260.25% | 17.87% | -154.39% | 710.51% |
